Cross-border M&A had its strongest start since 2007, driving first-quarter global volumes up 7 percent, as optimism over U.S. President Donald Trump’s economic agenda buoyed the stock market and the dollar, making foreign acquisitions cheaper than some U.S. targets.
Many U.S. CEOs are feeling richer and more confident thanks to a rally in their companies’ stock. Yet potential U.S. acquisition targets often feel they are worth a lot too, while uncertainty over Trump’s tax policies makes planning a merger more difficult for the companies involved.
To be sure, U.S. M&A was still up 3 percent in the first quarter. Some acquirers brushed off the political uncertainty, and often got around disagreements over the cash value of a company by using their stock as currency to pay for deals. Nonetheless, a few acquirers chose to cast their net overseas.
The biggest deal since the start of the year was U.S. healthcare